Apriori prediction of chemotherapy response in locally advanced breast cancer patients using CT imaging and deep learning: transformer versus transfer learning.

LABC ViT transformer deep learning neoadjuvant chemotherapy response prediction and CT imaging

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2024
Historique:
received: 20 12 2023
accepted: 16 04 2024
medline: 17 5 2024
pubmed: 17 5 2024
entrez: 17 5 2024
Statut: epublish

Résumé

Neoadjuvant chemotherapy (NAC) is a key element of treatment for locally advanced breast cancer (LABC). Predicting the response to NAC for patients with Locally Advanced Breast Cancer (LABC) before treatment initiation could be beneficial to optimize therapy, ensuring the administration of effective treatments. The objective of the work here was to develop a predictive model to predict tumor response to NAC for LABC using deep learning networks and computed tomography (CT). Several deep learning approaches were investigated including ViT transformer and VGG16, VGG19, ResNet-50, Res-Net-101, Res-Net-152, InceptionV3 and Xception transfer learning networks. These deep learning networks were applied on CT images to assess the response to NAC. Performance was evaluated based on balanced_accuracy, accuracy, sensitivity and specificity classification metrics. A ViT transformer was applied to utilize the attention mechanism in order to increase the weight of important part image which leads to better discrimination between classes. Amongst the 117 LABC patients studied, 82 (70%) had clinical-pathological response and 35 (30%) had no response to NAC. The ViT transformer obtained the best performance range (accuracy = 71 ± 3% to accuracy = 77 ± 4%, specificity = 86 ± 6% to specificity = 76 ± 3%, sensitivity = 56 ± 4% to sensitivity = 52 ± 4%, and balanced_accuracy=69 ± 3% to balanced_accuracy=69 ± 3%) depending on the split ratio of train-data and test-data. Xception network obtained the second best results (accuracy = 72 ± 4% to accuracy = 65 ± 4, specificity = 81 ± 6% to specificity = 73 ± 3%, sensitivity = 55 ± 4% to sensitivity = 52 ± 5%, and balanced_accuracy = 66 ± 5% to balanced_accuracy = 60 ± 4%). The worst results were obtained using VGG-16 transfer learning network. Deep learning networks in conjunction with CT imaging are able to predict the tumor response to NAC for patients with LABC prior to start. A ViT transformer could obtain the best performance, which demonstrated the importance of attention mechanism.

Identifiants

pubmed: 38756659
doi: 10.3389/fonc.2024.1359148
pmc: PMC11096486
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1359148

Informations de copyright

Copyright © 2024 Moslemi, Osapoetra, Dasgupta, Alberico, Trudeau, Gandhi, Eisen, Wright, Look-Hong, Curpen, Kolios and Czarnota.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Amir Moslemi (A)

Physical Sciences, Sunnybrook Research Institute, Toronto, ON, Canada.

Laurentius Oscar Osapoetra (LO)

Physical Sciences, Sunnybrook Research Institute, Toronto, ON, Canada.

Archya Dasgupta (A)

Physical Sciences, Sunnybrook Research Institute, Toronto, ON, Canada.

David Alberico (D)

Physical Sciences, Sunnybrook Research Institute, Toronto, ON, Canada.

Maureen Trudeau (M)

Department of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Department of Medicine, University of Toronto, Toronto, ON, Canada.

Sonal Gandhi (S)

Department of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Department of Medicine, University of Toronto, Toronto, ON, Canada.

Andrea Eisen (A)

Department of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Department of Medicine, University of Toronto, Toronto, ON, Canada.

Frances Wright (F)

Department of Surgical Oncology, Department of Surgery, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Department of Surgery, University of Toronto, Toronto, ON, Canada.

Nicole Look-Hong (N)

Department of Surgical Oncology, Department of Surgery, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Department of Surgery, University of Toronto, Toronto, ON, Canada.

Belinda Curpen (B)

Department of Medical Imaging, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.

Michael C Kolios (MC)

Department of Physics, Toronto Metropolitan University, Toronto, ON, Canada.

Gregory J Czarnota (GJ)

Physical Sciences, Sunnybrook Research Institute, Toronto, ON, Canada.
Department of Physics, Toronto Metropolitan University, Toronto, ON, Canada.
Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

Classifications MeSH